Continuous Glucose Monitoring in Adolescents with Type 1 Diabetes: Impact on Quality of Life, Physical Activity, and Health Education: A Narrative Review
DOI:
https://doi.org/10.12775/QS.2026.69.74508Keywords
type 1 diabetes, continuous glucose monitoring, adolescents, quality of life, physical activity, health education, psychosocial outcomesAbstract
Background: Adolescence introduces unique clinical, biological, and psychosocial complexities to type 1 diabetes (T1D) management. While continuous glucose monitoring (CGM) systems significantly improve metabolic outcomes, their impact on the overall quality of life (QoL) and psychological well-being remains nuanced.
Objective: This narrative review synthesizes current literature on the effects of CGM on QoL, psychosocial dynamics, and physical activity in adolescents with T1D, aiming to identify optimal strategies for integrated care.
Methods: A comprehensive search of PubMed, Scopus, and Web of Science (2015–2026) was conducted. Inclusion criteria covered peer-reviewed studies assessing CGM use, metabolic control, health-related QoL, and behavioral outcomes in pediatric populations and their caregivers.
Results: CGM use optimizes metabolic control by increasing time in range (TIR) and reducing hypoglycemia, particularly when integrated with automated insulin delivery (AID) systems. However, technological implementation alone does not guarantee improved QoL. This phenomenon can be framed as a “paradox of technological burden,” emerging through decision fatigue , alarm fatigue, and potential peer stigmatization. Therapeutic success heavily relies on subjective satisfaction, the perceived balance of benefits and burdens (the ABC Model), and socioeconomic equity. Furthermore, while CGM facilitates vigorous physical activity, it may induce a behavioral paradox characterized by technological over-reliance and reduced hypoglycemia avoidance behaviors.
Conclusions: CGM is a clinical milestone in T1D care, but maximizing its potential requires a shift from purely metabolic endpoints to holistic, patient-centered metrics. Addressing current literature gaps demands standardized psychometric tools and longitudinal, diverse cohorts. Routine mental health screening, family-centered health education, and equitable access policies are crucial for successful therapy.
References
Azar S, Maroun Abou Jaoude N, Kędzia A, Niechciał E. Barriers to Type 1 Diabetes Adherence in Adolescents. J Clin Med. 2024;13(19):5669. doi:10.3390/jcm13195669
Bai H, He N, Zhang Y, et al. Quality of Life and Glucose Regulation in Pediatric Patients with Type 1 Diabetes: A Study in the Ningxia Hui Autonomous Region. Diabetes Metab Syndr Obes. 2024;17:1267-1278. doi:10.2147/DMSO.S446387
Battelino T, Danne T, Bergenstal RM, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019;42(8):1593-1603. doi:10.2337/dci19-0028
Bombaci B, Torre A, Longo A, et al. Psychological and Clinical Challenges in the Management of Type 1 Diabetes during Adolescence: A Narrative Review. Children (Basel). 2024;11(9):1085. doi:10.3390/children11091085
Bratke H, Biringer E, Margeirsdottir HD, Njølstad PR, Skrivarhaug T. Relation of Health-Related Quality of Life with Glycemic Control and Use of Diabetes Technology in Children and Adolescents with Type 1 Diabetes: Results from a National Population Based Study. J Diabetes Res. 2022;2022:8401328. doi:10.1155/2022/8401328
Franceschi R, Micheli F, Mozzillo E, et al. Intermittently Scanned and Continuous Glucose Monitor Systems: A Systematic Review on Psychological Outcomes in Pediatric Patients. Front Pediatr. 2021;9:660173. doi:10.3389/fped.2021.660173
Franceschi R, Pertile R, Marigliano M, et al. Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type. Diabet Med. 2024;41(6):e15307. doi:10.1111/dme.15307
Gaszyńska M, Drzewiecka A, Drzewiecki A, et al. The role of physical activity in type 1 diabetes: a review of the literature. J Educ Health Sport. 2025;80:59766. doi:10.12785/jehs.80.59766
Giani E, Snelgrove R, Volkening LK, Laffel LM. Continuous Glucose Monitoring (CGM) Adherence in Youth With Type 1 Diabetes: Associations With Biomedical and Psychosocial Variables. J Diabetes Sci Technol. 2017;11(3):476-483. doi:10.1177/1932296816676280
Glocker V, Bachmann S, Hess M, Szinnai G, Burckhardt MA. Fear of hypoglycemia and quality of life in young people with type 1 diabetes and their parents in the era of sensor glucose monitoring. Front Endocrinol (Lausanne). 2022;13:958671. doi:10.3389/fendo.2022.958671
Jabbour G, Bragazzi NL. Continuous Blood Glucose Monitoring Increases Vigorous Physical Activity Levels and Is Associated With Reduced Hypoglycemia Avoidance Behavior In Youth With Type 1 Diabetes. Front Endocrinol (Lausanne). 2021;12:722123. doi:10.3389/fendo.2021.722123
Kowalczyk EM, Adamczyk M, Pietrzyk J, Jastrzębska B, Szypowska A. Continuous glucose monitoring systems in well-controlled children with type 1 diabetes mellitus. Pediatr Endocrinol Diabetes Metab. 2021;27(3):151-158. doi:10.5114/pedm.2021.107717
Kubiak T, Mann CG, Barnard KC, Heinemann L. Psychosocial Aspects of Continuous Glucose Monitoring: Connecting to the Patients' Experience. J Diabetes Sci Technol. 2016;10(4):859-863. doi:10.1177/1932296816651450
Laffel LM, Kanapka LG, Beck RW, et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2020;323(23):2388-2396. doi:10.1001/jama.2020.6940
Łoskot W, Szwech J, Matczak M, et al. Artificial intelligence in type 1 diabetes mellitus. J Educ Health Sport. 2025;79:57913. doi:10.12785/jehs.79.57913
Messer LH. Predicting Optimal Use of Continuous Glucose Monitors in Adolescents with Type 1 Diabetes: It’s About Benefit and Burden. Doctoral dissertation. University of Colorado; 2019. ProQuest No.: 27662789.
Miller KM, Bauza C, Kanapka LG, et al. Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results. Pediatr Diabetes. 2023;2023:6718115. doi:10.1155/2023/6718115
Ogle GD, Wang F, Haynes A, et al. Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: Results from the International diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0. Diabetes Res Clin Pract. 2025;225:112277. doi:10.1016/j.diabres.2025.112277
Patton SR, Clements MA. Psychological Reactions Associated With Continuous Glucose Monitoring in Youth. J Diabetes Sci Technol. 2016;10(3):656-661. doi:10.1177/1932296816638109
Rubelj K, Stipančić G, La Grasta Sabolić L, Požgaj Šepec M. Continuous glucose monitoring and type 1 diabetes mellitus control in child, adolescent and young adult population - arguments for its use and effects. Acta Clin Croat. 2021;60(4):609-616. doi:10.20471/acc.2021.60.04.07
Rusak E, Ogarek N, Wolicka K, et al. The Quality of Life and Satisfaction with Continuous Glucose Monitoring Therapy in Children under 7 Years of Age with T1D Using the rtCGM System Integrated with Insulin Pump-A Caregivers Point of View. Sensors (Basel). 2021;21(11):3683. doi:10.3390/s21113683
Stamford I. CGM for children and young people with type 1 diabetes: NICE criteria and effects of decision fatigue and alarm fatigue. Diabetes Care Children Young People. 2022;12(1):1-5.
Tauschmann M, Cardona-Hernandez R, DeSalvo DJ, et al. International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring. Horm Res Paediatr. 2024;97(6):615-635. doi:10.1159/000543156
Williams L, Deacon E, Van Rensburg E, Segal D. Continuous glucose monitoring empowers adolescents to take responsibility of diabetes management. Afr J Prim Health Care Fam Med. 2023;15(1):e1-e6. doi:10.4102/phcfm.v15i1.3879
Yeşil F, Çövener Özçelik Ç. Effect of Wearable Technology on Metabolic Control and the Quality of Life in Children and Adolescents with Type 1 Diabetes: A Systematic Review and Meta-Analysis. Balkan Med J. 2024;41(4):261-271. doi:10.4274/balkanmedj.galenos.2024.2024-2-115
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Maja Kowalczyk, Magdalena Wolff, Agata Sobczak, Lena Głuszkiewicz, Kalina Kreft, Anna Waldman

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 76
Number of citations: 0